Vietnam Continuous Glucose Monitoring Devices Market Report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Vietnam Continuous Glucose Monitoring Devices Market Overview

• The Vietnam Continuous Glucose Monitoring Devices Market is valued at USD 100 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of diabetes, rising healthcare expenditure, and advancements in technology that enhance patient monitoring and management. The demand for continuous glucose monitoring devices has surged as they provide real-time data, enabling better glycemic control and reducing the risk of complications associated with diabetes. Recent trends highlight the adoption of digital and minimally invasive solutions, including AI-integrated mobile apps and Bluetooth-enabled insulin pens, further supporting market expansion .
• Key cities such asHo Chi Minh CityandHanoidominate the market due to their high population density, advanced healthcare infrastructure, and increasing awareness of diabetes management. These urban centers are also home to a significant number of healthcare facilities and diabetes clinics, which facilitate the adoption of continuous glucose monitoring devices among patients and healthcare providers. Urban clinics report higher CGM adoption rates, with penetration among insulin users in major hospitals rising steadily .
• In 2024, the Vietnamese government expanded its national diabetes prevention and control program, including the implementation of reimbursement for continuous glucose monitoring devices under the National Health Insurance scheme. This initiative, formalized through the Ministry of Health’s reimbursement policy, covers both sensors and transmitters for insulin-dependent and hospitalized patients, reducing out-of-pocket costs and supporting broader access. The program aims to improve diabetes management and reduce the burden of diabetes-related complications, thereby enhancing the overall health of the population .

Vietnam Continuous Glucose Monitoring Devices Market Segmentation

By Device Type:The market is segmented into various device types, including Real-time Continuous Glucose Monitoring (rtCGM) Systems, Intermittently Scanned Continuous Glucose Monitoring (isCGM) Systems, Sensor Components, and Others. Among these,Real-time Continuous Glucose Monitoring (rtCGM) Systemsare leading the market due to their ability to provide continuous data and alerts, which are crucial for effective diabetes management. The increasing adoption of these systems is driven by their user-friendly features and the growing demand for personalized healthcare solutions. The adoption of advanced sensor technology and AI-driven analytics is further accelerating the uptake of rtCGM systems .

By End-User:The end-user segmentation includes Hospitals, Home Care Settings, Diabetes Clinics & Endocrinology Centers, Pharmacies & Retailers, and Others.Hospitalsare the dominant end-user segment, as they are equipped with advanced medical technologies and have a higher patient volume requiring continuous glucose monitoring. The increasing number of diabetes patients seeking treatment in hospitals drives the demand for these devices, as they are essential for effective patient management and monitoring. The expansion of reimbursement coverage and standardized clinical guidelines has also increased CGM utilization in both hospital and home care settings .

Vietnam Continuous Glucose Monitoring Devices Market Competitive Landscape

The Vietnam Continuous Glucose Monitoring Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories, Dexcom, Inc., Medtronic plc, Roche Diabetes Care, Ascensia Diabetes Care Holdings AG, Senseonics Holdings, Inc., GlySens Incorporated, Insulet Corporation, Nova Biomedical, Ypsomed AG, FreeStyle Libre (Abbott), Glooko, Inc., Eversense (Senseonics), LifeScan, Inc., DarioHealth Corp., Medovate Vietnam Co., Ltd., Vietmedical (Vietmedical Group), DKSH Vietnam Co., Ltd., FPT Healthcare contribute to innovation, geographic expansion, and service delivery in this space.

Vietnam Continuous Glucose Monitoring Devices Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Diabetes:The prevalence of diabetes in Vietnam has reached approximately 4.8 million cases, with projections indicating a rise to 6.3 million in future. This alarming trend is driven by urbanization, lifestyle changes, and dietary habits. The World Health Organization (WHO) reports that diabetes-related healthcare costs in Vietnam are expected to exceed $1.1 billion annually, highlighting the urgent need for effective management solutions, including continuous glucose monitoring devices.
• Rising Awareness About Diabetes Management:Increased public awareness campaigns and educational initiatives have significantly improved knowledge about diabetes management in Vietnam. The Ministry of Health reported that over 70% of the population is now aware of diabetes risks and management strategies. This heightened awareness has led to a growing demand for continuous glucose monitoring devices, as patients seek better tools to manage their condition effectively and reduce complications associated with diabetes.
• Technological Advancements in Monitoring Devices:The continuous glucose monitoring devices market in Vietnam is benefiting from rapid technological advancements. Innovations such as real-time data tracking and integration with mobile applications have enhanced user experience. In future, it is estimated that over 30% of glucose monitoring devices will incorporate advanced features like AI-driven analytics, improving accuracy and user engagement. This technological evolution is crucial for meeting the needs of a tech-savvy population increasingly reliant on digital health solutions.

Market Challenges

• High Cost of Continuous Glucose Monitoring Devices:The high cost of continuous glucose monitoring devices remains a significant barrier to widespread adoption in Vietnam. Prices for these devices can range from $300 to $1,000, making them unaffordable for many patients, especially in rural areas. The average monthly income in Vietnam is approximately $300, which means that many individuals cannot allocate sufficient funds for diabetes management technologies, limiting market growth potential.
• Limited Reimbursement Policies:The lack of comprehensive reimbursement policies for continuous glucose monitoring devices poses a challenge for market expansion. Currently, only a small percentage of health insurance plans in Vietnam cover these devices, leaving patients to bear the full financial burden. According to the Vietnam Social Security, only 15% of diabetes patients have access to reimbursement for monitoring devices, which significantly hampers the adoption rate and overall market growth.

Vietnam Continuous Glucose Monitoring Devices Market Future Outlook

The future of the continuous glucose monitoring devices market in Vietnam appears promising, driven by increasing healthcare investments and a growing focus on chronic disease management. With the government aiming to enhance healthcare infrastructure, the integration of advanced technologies in diabetes care is expected to rise. Additionally, the collaboration between tech companies and healthcare providers will likely foster innovation, leading to more accessible and affordable monitoring solutions for patients, ultimately improving health outcomes across the nation.

Market Opportunities

• Expansion of Telehealth Services:The rapid growth of telehealth services in Vietnam presents a significant opportunity for continuous glucose monitoring devices. With over 20 million telehealth consultations conducted in future, integrating glucose monitoring solutions into these platforms can enhance patient engagement and adherence to treatment plans, ultimately improving diabetes management outcomes.
• Development of Affordable Monitoring Solutions:There is a pressing need for affordable continuous glucose monitoring solutions in Vietnam. By focusing on cost-effective device development, manufacturers can tap into a large segment of the population that currently lacks access to these technologies. This approach could potentially increase market penetration and improve diabetes management for millions of patients across the country.